ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Neurology

Top Neurology Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GEORGE RICAURTE M.D.

Neurology

165

$46.9K

35
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$284
Average prescription price

Avg: $247

ARASH FOROUGHI M.D.

Neurology

184

$8,400

34
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $247

JOHN LATERRA M.D.

Neurology

188

$33K

23
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 28%

$175
Average prescription price

Avg: $247

MICHAEL LEVY M.D., PH.D.

Neurology

198

$335K

26
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 28%

$1692
Average prescription price

Avg: $247

MELISSA ARMSTRONG MD

Neurology

241

$42K

61
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 28%

$174
Average prescription price

Avg: $247

JENNIFER HOPP M.D.

Neurology

247

$83.5K

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 28%

$338
Average prescription price

Avg: $247

ANDREA CORSE M.D.

Neurology

254

$120K

44
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 28%

$471
Average prescription price

Avg: $247

CATHERINE GRIFFIN MD

Neurology

267

$62.5K

52
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$234
Average prescription price

Avg: $247

ANA SANCHEZ MD

Neurology

279

$34.8K

32
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 28%

$125
Average prescription price

Avg: $247

NED SACKTOR M.D.

Neurology

288

$77.3K

72
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 28%

$269
Average prescription price

Avg: $247

BRIGIT VENZA MD

Neurology

301

$86.9K

105
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 28%

$289
Average prescription price

Avg: $247

ELLA AKKERMAN MD

Neurology

318

$22.9K

125
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 28%

$72
Average prescription price

Avg: $247

VINAY CHAUDHRY M.D.

Neurology

328

$191K

66
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$583
Average prescription price

Avg: $247

ALAN FRIEDMAN M.D.

Neurology

330

$21.9K

84
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $247

FRANCIS TIROL MD

Neurology

338

$61.6K

47
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 28%

$182
Average prescription price

Avg: $247

CHEUNJU CHEN M.D.

Neurology

343

$19.7K

75
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 28%

$58
Average prescription price

Avg: $247

BRYAN CUPKA MD

Neurology

344

$41.3K

59
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 28%

$120
Average prescription price

Avg: $247

KIMBERLY PARGEON MD

Neurology

374

$38.2K

46
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 28%

$102
Average prescription price

Avg: $247

TARIQ MAHMOOD MD

Neurology

404

$29.1K

75
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 28%

$72
Average prescription price

Avg: $247

HARVEY PATS M.D.

Neurology

418

$238K

85
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 28%

$570
Average prescription price

Avg: $247

RICHARD TAYLOR M.D., F.A.A.N.

Neurology

447

$315K

73
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 28%

$705
Average prescription price

Avg: $247

FRANKO STEPCIC MD

Neurology

467

$50.6K

74
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 28%

$108
Average prescription price

Avg: $247

SANDRA RUBY MD

Neurology

479

$53.6K

93
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$112
Average prescription price

Avg: $247

MAYA CARTER MD

Neurology

493

$45.3K

94
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $247

BEENA SHAH

Neurology

498

$71.7K

107
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$144
Average prescription price

Avg: $247

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank